These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16611860)

  • 1. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis.
    Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S
    Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.
    Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T
    Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective toxicity of aristolochic acids I and II.
    Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP
    Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
    Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
    Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.
    Debelle F; Nortier J; Arlt VM; De Prez E; Vienne A; Salmon I; Phillips DH; Deschodt-Lanckman M; Vanherweghem JL
    Arch Toxicol; 2003 Apr; 77(4):218-26. PubMed ID: 12698237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
    Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
    Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
    Guo L; Wu H; Yue H; Lin S; Lai Y; Cai Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):153-8. PubMed ID: 21177145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA.
    Pfau W; Schmeiser HH; Wiessler M
    Carcinogenesis; 1990 Feb; 11(2):313-9. PubMed ID: 2302759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.
    Yun BH; Rosenquist TA; Sidorenko V; Iden CR; Chen CH; Pu YS; Bonala R; Johnson F; Dickman KG; Grollman AP; Turesky RJ
    Chem Res Toxicol; 2012 May; 25(5):1119-31. PubMed ID: 22515372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.
    Schmeiser HH; Bieler CA; Wiessler M; van Ypersele de Strihou C; Cosyns JP
    Cancer Res; 1996 May; 56(9):2025-8. PubMed ID: 8616845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.